SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001811764-23-000007
Filing Date
2023-03-27
Accepted
2023-03-27 07:53:56
Documents
111
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K pnt-20221231.htm   iXBRL 10-K 2100265
2 EX-10.9 exhibit109-pointbiopharma2.htm EX-10.9 23688
3 EX-10.17 exhibit1017-firstamendment.htm EX-10.17 43195
4 EX-23.1 exhibit231-consentofindipe.htm EX-23.1 3138
5 EX-31.1 exhibit311-10kx12312022.htm EX-31.1 11465
6 EX-31.2 exhibit312-10kx12312022.htm EX-31.2 12208
7 EX-32 exhibit32-10kx12312022.htm EX-32 9079
13 pnt-20221231_g1.jpg GRAPHIC 181884
14 pnt-20221231_g2.jpg GRAPHIC 113277
15 pnt-20221231_g3.jpg GRAPHIC 111533
16 pnt-20221231_g4.jpg GRAPHIC 133374
17 pnt-20221231_g5.jpg GRAPHIC 83301
18 pnt-20221231_g6.jpg GRAPHIC 127020
19 pnt-20221231_g7.jpg GRAPHIC 105613
20 pnt-20221231_g8.jpg GRAPHIC 237231
  Complete submission text file 0001811764-23-000007.txt   11748498

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pnt-20221231.xsd EX-101.SCH 67280
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pnt-20221231_cal.xml EX-101.CAL 89796
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pnt-20221231_def.xml EX-101.DEF 348831
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pnt-20221231_lab.xml EX-101.LAB 752136
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pnt-20221231_pre.xml EX-101.PRE 542913
105 EXTRACTED XBRL INSTANCE DOCUMENT pnt-20221231_htm.xml XML 954759
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39373 | Film No.: 23761457
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences